Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted ...

COVID symptoms can be mild, severe, or nonexistent, according to the CDC—and can appear as late as two weeks after you’ve ...

As I ran the National Institutes of Health during the pandemic, I learned that something deep within our culture is wrong.

I am deeply troubled by the growing distrust of science in our society, just at the time when its insights are most needed.

Aditxt, Inc. ("Aditxt" or the "Company"), an innovation platform dedicated to accelerating promising health innovations, today announced that its majority-owned subsidiary, Pearsanta, Inc. ("Pearsanta ...

The strain is a subvariant of Omicron, and was found in Germany this June, with other cases reported in Denmark, U.S. and U.K. Janis Ramsay is an online editor with Metroland. Reach her at ...

The room was lit in pink and green, the colors of Alpha Kappa Alpha, the nation’s oldest black sorority. The Hartford chapter, Epsilon Omicron Omega, and the Foundation for Educational Opportunities ...

By mid-September, the Centers for Disease Control and Prevention reported the Omicron subvariant KP.3. ... If you display any of the above symptoms and test positive for COVID-19, you may have ...

It’s not a new strain requiring another Greek letter designation, and it hasn't been shown to cause more severe disease compared to other Omicron subvariants. However, with colder months ...

The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent ...